The Exchange has sought clarification from Akzo Nobel India Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
JSWDULUX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE has asked Akzo Nobel India Limited to clarify discrepancies found in the financial results filed in XBRL format for the quarter ended 31 March 2025. This is under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, which governs the submission of audited or unaudited financial results. The company has not yet responded to the exchange's query. Investors are awaiting the company's clarification to understand the nature of the discrepancies.
This is a routine regulatory query on filing format discrepancies and does not necessarily indicate a problem with the underlying financials. However, until the company responds and clarifies, the filing remains under review, which may cause minor uncertainty for shareholders. No immediate impact on the stock price is expected unless the clarification reveals a substantive issue.